BDBM100860 US8507533, 187::US8507533, 189::US8507533, 450

SMILES CCCC(Oc1cc(C)c(c(C)c1)-n1cc2ccccc2n1)c1ccc(cc1)C(=O)NCCC(O)=O

InChI Key InChIKey=QCOPOVBWEJSWFQ-UHFFFAOYSA-N

Data  1 KI

  Tab Delimited (TSV)   2D SDfile   Computed 3D by Vconf -m prep SDfile
Find this compound or compounds like it in BindingDB:
   Substructure
Similarity at least:  must be >=0.5
Exact match

Activity Spreadsheet -- Enzyme Inhibition Constant Data from BindingDB

Found 1 hit for monomerid = 100860   

TargetPro-glucagon(Human)
Pfizer

US Patent
LigandPNGBDBM100860(US8507533, 450 | US8507533, 189 | US8507533, 187)
Affinity DataKi:  109nMpH: 7.4Assay Description:The Glucagon SPA assay is used to determine the ability of test compounds to block the binding of glucagon-cex to the glucagon receptors.More data for this Ligand-Target Pair
In Depth
Date in BDB:
10/7/2013
Entry Details
Go to US Patent